Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Zydus Lifesciences Limited (NSE: ZYDUSLIFE), ISIN INE010B01027 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
ZYDUSLIFE last traded at ₹1211.60 (+1.01%), with a 52-week range of ₹835.50 to ₹1266.60 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 75.01%, FIIs 7.05%, DIIs 11.28%, mutual funds 6.88%.
EquiSense Score (ECS): 78/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.